If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Software Group Regulatory News (APTD)

Share Price Information for Aptitude Software Group (APTD)

Share Price is delayed by 15 minutes
Get Live Data
213.00    1.00 (0.47%)
Bid:
208.00
Ask:
220.00
Spread: 12.00 (5.769%)
Market Cap: £112.45m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Software Group Share Chart

Director/PDMR Shareholding

16 Mar 2017 16:31

RNS Number : 7386Z
Microgen PLC
16 March 2017
Β 

16 March 2017

Β 

MICROGEN plc (the "Company")

Β 

Director/PDMR Shareholding / Total Voting Rights

Β 

Microgen plc (LSE: MCGN), a leading provider of business critical software and services, provides notification that on 16 March 2017, following the exercise by a number of the Company's Executive Directors of options under the Microgen Plc Performance Share Plan 2006 ("PSP"), 780,618 new ordinary shares of 6 3/7 pence each in the Company ("Ordinary Shares") have been issued. The issued Ordinary Shares were admitted to the Official List of the UKLA and to trading on the main market of the London Stock Exchange on 25 November 2016.

Β 

Each of the Executive Directors named below exercised options over the number of Ordinary Shares specified below on 16 March 2017 with an exercise price per Ordinary Share of Β£0.05. The options had an expiry date of 18 November 2023.

Β 

Following the exercise of these options each Executive Director's overall shareholding in the Company has increased as set out in the following table. Each Executive Director also sold a number of the resulting Ordinary Shares on 16 March 2017 at a price of Β£2.70 per Ordinary Share, as set out below.

Β 

Name of Executive Director

No. of Options Exercised

No. of Ordinary Shares sold

No. of Ordinary Shares held prior to transactions

Number of Ordinary Shares held after transactions

Β 

Percentage of the issued share capital of the Company held prior to transactions

Percentage of the issued share capital of the Company held after transactions

Tom Crawford (CEO, Aptitude Software)

140,206

69,757

309,551

380,000

0.52%

0.63%

Simon Baines (CEO, Microgen Financial Systems)

320,206

229,729

9,523

100,000

0.02%

0.16%

Philip Wood (Chief Financial Officer)

320,206

230,841

110,635

200,000

0.18%

0.33%

Β 

In accordance with DTR 5.6.1, the Company also announces that, following the transactions referred to above, as at today's date, its issued share capital comprises 60,771,938 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. The voting rights of all of the Ordinary Shares are identical. Shareholders may use this figure as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Ordinary Shares in Microgen under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

Β 

The notification below, made pursuant to Article 19 of Regulation (EU) No 596/2014 on Market Abuse, provides further information about these transactions.

Β 

1

Details of the person discharging managerial responsibilities / person closely associated

Β 

(a)

Name

(i) Tom Crawford

(ii) Simon Baines

(iii) Philip Wood

Β 

2

Reason for the notification

Β 

(a)

Position/Status

(i) PDMR - (Chief Executive Officer, Aptitude Software)

(ii) PDMR - (Chief Executive Officer, Microgen Financial Systems)

(iii) PDMR - (Chief Financial Officer)

Β 

(b)

Initial notification / Amendment

Initial notification

Β 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

(a)

Name

Microgen Plc

Β 

(b)

LEI

2138009VHA1WI2VKMA28

Β 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

(a)

Description of the financial instrument, type of instrument

Β 

Identification Code

Β 

Ordinary Shares of 6 3/7 pence each

Β 

Β 

ISIN: GB00BVVHWX30

(b)

Nature of the transaction

Β 

(a) Exercise of options over Ordinary Shares

(b) Sale of Ordinary Shares

Β 

(c)

Price(s) and volume(s)

Β 

Name

(a) Exercise Price per Ordinary Share

(a) Number of Ordinary Shares over which Options Exercised

(b) Sale Price per Ordinary Share

(b) Number of Ordinary Shares sold

(i) Tom Crawford

Β£0.05

140,206

Β£2.70

69,757

(ii) Simon Baines

Β£0.05

320,206

Β£2.70

229,729

(iii) Philip Wood

Β£0.05

320,206

Β£2.70

230,841

(d)

Aggregated Information

- Aggregated Volume

- Price

n/a

(e)

Date of the Transaction

16 March 2017

Β 

(f)

Place of the Transaction

(a) Outside a trading venue

(b) London Stock Exchange (XLON)

Β 

Name of authorised official of issuer responsible for making notification:

Mark Heather, Company Secretary, Microgen Plc

Β 

Contacts

Mark Heather, Company Secretary 020-7496-8100

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHGGUMPWUPMGQQ
Date   Source Headline
29th Apr 20257:00 amRNSNotice of 2025 Annual General Meeting
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20254:16 pmRNSExercise of awards under the Aptitude 2020 DBP
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSAptitude Fynapse New Contract Win
3rd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 202511:49 amRNSTotal Voting Rights
31st Mar 202510:29 amRNSNotification of Major Holdings
31st Mar 202510:11 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20255:01 pmRNSNotification of Major Holdings
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20255:10 pmRNSDirectorate Change
26th Mar 20257:00 amRNSAudited Results for Year Ended 31 December 2024
20th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20258:46 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:01 amRNSBoard Transition
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 202510:43 amRNSTotal Voting Rights
31st Jan 20255:39 pmRNSNotification of Major Holdings
30th Jan 20254:58 pmRNSNotification of Major Holdings
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 202510:41 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.